P48960 (CD97_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 138.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: CD97 antigen Alternative name(s): Leukocyte antigen CD97 CD_antigen=CD97 Cleaved into the following 2 chains: | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 835 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor potentially involved in both adhesion and signaling processes early after leukocyte activation. Plays an essential role in leukocyte migration By similarity. |
| Subunit structure | Forms a heterodimer, consisting of a large extracellular region (alpha subunit) non-covalently linked to a seven-transmembrane moiety (beta subunit). Interacts with complement decay-accelerating factor (DAF). The largest isoform 1) interacts with chondroitin sulfate. Ref.10 Ref.11 |
| Subcellular location | |
| Tissue specificity | Broadly expressed, found on most hematopoietic cells, including activated lymphocytes, monocytes, macrophages, dendritic cells, and granulocytes. Expressed also abundantly by smooth muscle cells. Expressed in thyroid, colorectal, gastric, esophageal and pancreatic carcinomas too. Expression are increased under inflammatory conditions in the CNS of multiple sclerosis and in synovial tissue of patients with rheumatoid arthritis. Increased expression of CD97 in the synovium is accompanied by detectable levels of soluble CD97 in the synovial fluid. |
| Induction | Rapid up-regulation during lymphocyte activation. |
| Domain | The first two EGF domains mediate the interaction with DAF. A third tandemly arranged EGF domain is necessary for the structural integrity of the binding region. Binding to chondroitin sulfate is mediated by the fourth EGF domain. |
| Post-translational modification | Proteolytically cleaved into 2 subunits, an extracellular alpha subunit and a seven-transmembrane subunit By similarity. |
| Sequence similarities | Belongs to the G-protein coupled receptor 2 family. LN-TM7 subfamily. Contains 5 EGF-like domains. Contains 1 GPS domain. |
| Sequence caution | The sequence AAC27673.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence BAC06178.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P48960-1) Also known as: EGF(1,2,3,4,5); This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P48960-2) Also known as: EGF(1,2,5); The sequence of this isoform differs from the canonical sequence as follows: 116-208: Missing. | ||||||
| Isoform 3 (identifier: P48960-3) Also known as: EGF(1,2,3,5); The sequence of this isoform differs from the canonical sequence as follows: 160-208: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 20 | 20 | Potential | ||||||||
| Chain | 21 – 835 | 815 | CD97 antigen | PRO_0000012868 | |||||||
| Chain | 21 – 530 | 510 | CD97 antigen subunit alpha By similarity | PRO_0000296235 | |||||||
| Chain | 531 – 835 | 305 | CD97 antigen subunit beta By similarity | PRO_0000296236 | |||||||
Regions | |||||||||||
| Topological domain | 21 – 552 | 532 | Extracellular Potential | ||||||||
| Transmembrane | 553 – 572 | 20 | Helical; Name=1; Potential | ||||||||
| Topological domain | 573 – 581 | 9 | Cytoplasmic Potential | ||||||||
| Transmembrane | 582 – 601 | 20 | Helical; Name=2; Potential | ||||||||
| Topological domain | 602 – 620 | 19 | Extracellular Potential | ||||||||
| Transmembrane | 621 – 642 | 22 | Helical; Name=3; Potential | ||||||||
| Topological domain | 643 – 653 | 11 | Cytoplasmic Potential | ||||||||
| Transmembrane | 654 – 674 | 21 | Helical; Name=4; Potential | ||||||||
| Topological domain | 675 – 691 | 17 | Extracellular Potential | ||||||||
| Transmembrane | 692 – 712 | 21 | Helical; Name=5; Potential | ||||||||
| Topological domain | 713 – 739 | 27 | Cytoplasmic Potential | ||||||||
| Transmembrane | 740 – 760 | 21 | Helical; Name=6; Potential | ||||||||
| Topological domain | 761 – 766 | 6 | Extracellular Potential | ||||||||
| Transmembrane | 767 – 789 | 23 | Helical; Name=7; Potential | ||||||||
| Topological domain | 790 – 835 | 46 | Cytoplasmic Potential | ||||||||
| Domain | 22 – 63 | 42 | EGF-like 1 | ||||||||
| Domain | 64 – 115 | 52 | EGF-like 2; calcium-binding Potential | ||||||||
| Domain | 116 – 159 | 44 | EGF-like 3; calcium-binding Potential | ||||||||
| Domain | 160 – 208 | 49 | EGF-like 4; calcium-binding Potential | ||||||||
| Domain | 209 – 257 | 49 | EGF-like 5; calcium-binding Potential | ||||||||
| Domain | 492 – 542 | 51 | GPS | ||||||||
Sites | |||||||||||
| Site | 530 – 531 | 2 | Cleavage By similarity | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 831 | 1 | Phosphoserine Ref.17 | ||||||||
| Modified residue | 833 | 1 | Phosphoserine Ref.17 | ||||||||
| Glycosylation | 33 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 38 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 108 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 203 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 371 | 1 | N-linked (GlcNAc...) Ref.16 | ||||||||
| Glycosylation | 406 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 413 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 453 | 1 | N-linked (GlcNAc...) Ref.15 | ||||||||
| Glycosylation | 520 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 26 ↔ 36 | By similarity | |||||||||
| Disulfide bond | 30 ↔ 42 | By similarity | |||||||||
| Disulfide bond | 44 ↔ 62 | By similarity | |||||||||
| Disulfide bond | 68 ↔ 82 | By similarity | |||||||||
| Disulfide bond | 76 ↔ 91 | By similarity | |||||||||
| Disulfide bond | 93 ↔ 114 | By similarity | |||||||||
| Disulfide bond | 120 ↔ 133 | By similarity | |||||||||
| Disulfide bond | 127 ↔ 142 | By similarity | |||||||||
| Disulfide bond | 144 ↔ 158 | By similarity | |||||||||
| Disulfide bond | 164 ↔ 177 | By similarity | |||||||||
| Disulfide bond | 171 ↔ 186 | By similarity | |||||||||
| Disulfide bond | 188 ↔ 207 | By similarity | |||||||||
| Disulfide bond | 213 ↔ 226 | By similarity | |||||||||
| Disulfide bond | 220 ↔ 235 | By similarity | |||||||||
| Disulfide bond | 237 ↔ 256 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 116 – 208 | 93 | Missing in isoform 2. | VSP_009411 | |||||||
| Alternative sequence | 160 – 208 | 49 | Missing in isoform 3. | VSP_009412 | |||||||
| Natural variant | 367 | 1 | R → Q. Corresponds to variant rs2230748 [ dbSNP | Ensembl ]. | VAR_017760 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 103 | 1 | A → T in AAB36682. Ref.4 | ||||||||
| Sequence conflict | 512 | 1 | G → V Ref.1 | ||||||||
| Sequence conflict | 512 | 1 | G → V Ref.2 | ||||||||
| Sequence conflict | 534 | 1 | A → T Ref.1 | ||||||||
| Sequence conflict | 534 | 1 | A → T Ref.2 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretion receptor superfamily with an unusual extracellular domain." Hamann J., Eichler W., Hamann D., Kerstens H.M.J., Poddighe P.J., Hoovers J.M.N., Hartmann J.M., Strauss M., van Lier R.A.W. J. Immunol. 155:1942-1950(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [2] | "Structure of the human CD97 gene: exon shuffling has generated a new type of seven-span transmembrane molecule related to the secretin receptor superfamily." Hamann J., Hartmann E., van Lier R.A.W. Genomics 32:144-147(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1). Tissue: Foreskin. |
| [3] | Hamann J. Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION. |
| [4] | "CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation." Gray J.X., Haino M., Roth M.J., Maguire J.E., Jensen P.N., Yarme A., Stetler-Stevenson M.-A., Siebenlist U., Kelly K. J. Immunol. 157:5438-5447(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3). |
| [5] | "Genome-wide discovery and analysis of human seven transmembrane helix receptor genes." Suwa M., Sato T., Okouchi I., Arita M., Futami K., Matsumoto S., Tsutsumi S., Aburatani H., Asai K., Akiyama Y. Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [6] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Placenta and Synovium. |
| [7] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Colon adenocarcinoma. |
| [10] | "Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex." Lin H.-H., Stacey M., Saxby C., Knott V., Chaudhry Y., Evans D., Gordon S., McKnight A.J., Handford P., Lea S. J. Biol. Chem. 276:24160-24169(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DAF. |
| [11] | "The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans." Stacey M., Chang G.-W., Davies J.Q., Kwakkenbos M.J., Sanderson R.D., Hamann J., Gordon S., Lin H.-H. Blood 102:2916-2924(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CHONDROITIN SULFATE. |
| [12] | "The EGF-TM7 family: a postgenomic view." Kwakkenbos M.J., Kop E.N., Stacey M., Matmati M., Gordon S., Lin H.H., Hamann J. Immunogenetics 55:655-666(2004) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [13] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [14] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [15] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-453, MASS SPECTROMETRY. Tissue: Liver. |
| [16] | "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins." Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D. Nat. Biotechnol. 27:378-386(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-371, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [17] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-831 AND SER-833, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | X84700 mRNA. Translation: CAA59173.1. X94630 X94647 Genomic DNA. Translation: CAA64333.1.U76764 mRNA. Translation: AAB36682.1. AB065966 Genomic DNA. Translation: BAC06178.1. Sequence problems. AC005327 Genomic DNA. Translation: AAC27673.1. Sequence problems. AK292159 mRNA. Translation: BAF84848.1. AK314697 mRNA. Translation: BAG37246.1. CH471106 Genomic DNA. Translation: EAW84412.1. CH471106 Genomic DNA. Translation: EAW84413.1. BC026690 mRNA. Translation: AAH26690.1. |
| IPI | IPI00299412. IPI00397229. IPI00397230. |
| PIR | I37225. |
| RefSeq | NP_001020331.1. NM_001025160.2. NP_001775.2. NM_001784.4. NP_510966.1. NM_078481.3. |
| UniGene | Hs.466039. |
3D structure databases | |
| ProteinModelPortal | P48960. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-52292N. |
| IntAct | P48960. 3 interactions. |
| MINT | MINT-4531069. |
| STRING | 9606.ENSP00000242786. |
Protein family/group databases | |
| MEROPS | S63.002. |
| GPCRDB | Search... |
PTM databases | |
| PhosphoSite | P48960. |
Polymorphism databases | |
| DMDM | 90110013. |
Proteomic databases | |
| PaxDb | P48960. |
| PRIDE | P48960. |
Protocols and materials databases | |
| DNASU | 976. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000242786; ENSP00000242786; ENSG00000123146. ENST00000357355; ENSP00000349918; ENSG00000123146. ENST00000358600; ENSP00000351413; ENSG00000123146. |
| GeneID | 976. |
| KEGG | hsa:976. |
| UCSC | uc002myl.3. human. uc002mym.3. human. uc002myn.3. human. |
Organism-specific databases | |
| CTD | 976. |
| GeneCards | GC19P014492. |
| HGNC | HGNC:1711. CD97. |
| HPA | HPA013707. |
| MIM | 601211. gene. |
| neXtProt | NX_P48960. |
| PharmGKB | PA26248. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG320737. |
| HOVERGEN | HBG048917. |
| InParanoid | P48960. |
| KO | K08446. |
| OMA | REEYRKW. |
| OrthoDB | EOG45X7WF. |
| PhylomeDB | P48960. |
Enzyme and pathway databases | |
| Reactome | REACT_111102. Signal Transduction. |
Gene expression databases | |
| Bgee | P48960. |
| CleanEx | HS_CD97. |
| Genevestigator | P48960. |
| GermOnline | ENSG00000123146. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR000742. EG-like_dom. IPR001881. EGF-like_Ca-bd. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR018097. EGF_Ca-bd_CS. IPR017981. GPCR_2-like. IPR003056. GPCR_2_CD97. IPR000832. GPCR_2_secretin-like. IPR017983. GPCR_2_secretin-like_CS. IPR000203. GPS_dom. [Graphical view] |
| Pfam | PF00002. 7tm_2. 1 hit. PF07645. EGF_CA. 4 hits. PF01825. GPS. 1 hit. [Graphical view] |
| PRINTS | PR01278. CD97PROTEIN. PR00249. GPCRSECRETIN. |
| SMART | SM00179. EGF_CA. 4 hits. SM00303. GPS. 1 hit. [Graphical view] |
| PROSITE | PS00010. ASX_HYDROXYL. 4 hits. PS50026. EGF_3. 4 hits. PS01187. EGF_CA. 4 hits. PS00650. G_PROTEIN_RECEP_F2_2. 1 hit. PS50261. G_PROTEIN_RECEP_F2_4. 1 hit. PS50221. GPS. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | CD97. human. |
| GenomeRNAi | 976. |
| NextBio | 4094. |
| SOURCE | Search... |
Entry information
| Entry name | CD97_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P48960 Secondary accession number(s): A8K7Z4 Q8TBQ7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| 7-transmembrane G-linked receptors List of 7-transmembrane G-linked receptor entries |
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
